Jg. Tibben et al., EFFECT OF THE ROUTE OF ADMINISTRATION ON THE BIODISTRIBUTION OF RADIOIODINATED OV-TL 3 F(AB')2 IN EXPERIMENTAL OVARIAN-CANCER, European journal of nuclear medicine, 21(11), 1994, pp. 1183-1190
The effect of the route administration on the distribution of radioiod
inated OV-TL 3 F(ab')(2) was studied in Balb/c female mice with intrap
eritoneal or subcutaneous ovarian carcinoma xenografts. In the intrape
ritoneal tumour model in which both ascites and solid tumour deposits
were present, intraperitoneal administration resulted in a lower estim
ated radiation dose to blood as compared with intravenous administrati
on. In this model normalization to equal estimated radiation doses to
blood for both routes of administration indicated that a twice as high
estimated radiation dose can be guided to solid intraperitoneal tumou
r deposits following intraperitoneal administration. Evacuation of asc
itic tumour cells prior to monoclonal antibody injection further incre
ased the estimated radiation dose to solid intraperitoneal tumour depo
sits following intraperitoneal delivery. Following simultaneous intrav
enous and intraperitoneal injection of the monoclonal antibody, tissue
uptake showed no relevant differences in the subcutaneous tumour mode
l. Overall, the intraperitoneal route of administration was found to b
e the best choice for therapeutic delivery of iodine-131 labelled mono
clonal antibodies.